Shemesh Shay 4
4 · Nuvectis Pharma, Inc. · Filed Jan 13, 2023
Insider Transaction Report
Form 4
Shemesh Shay
Chief Dev. & Ops. Officer
Transactions
- Award
Common Stock
2023-01-12+115,000→ 1,360,865 total
Footnotes (2)
- [F1]The restricted stock units will vest according to the following schedule: one-third on each of 01/12/2024, 01/12/2025, and 01/12/2026.
- [F2]Includes 48,399 shares of restricted stock and 175,000 restricted stock units.